OP0047 Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Study

P. Taylor; M. C. Genovese; E. Keystone; D. Schlichting; S. Beattie; W. Macias

doi:10.1136/annrheumdis-2013-eular.252

OP0047 Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.252 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A65.2-A66 ◽

Cited By ~ 2

Author(s):

P. Taylor ◽

M. C. Genovese ◽

E. Keystone ◽

D. Schlichting ◽

S. Beattie ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Extension Study ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy

Download Full-text

THU0197 Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 8 years

10.1136/annrheumdis-2017-eular.1166 ◽

2017 ◽

Cited By ~ 4

Author(s):

J Wollenhaupt ◽

J Silverfield ◽

EB Lee ◽

K Terry ◽

K Kwok ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy

Download Full-text

THU0179 Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-label, Long-term Extension up to 6 Years

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.2859 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 259.1-259 ◽

Cited By ~ 4

Author(s):

J. Wollenhaupt ◽

J. Silverfield ◽

E.B. Lee ◽

S.P. Wood ◽

K.K. Terry ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy

Download Full-text

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Arthritis Research & Therapy ◽

10.1186/s13075-016-0932-2 ◽

2016 ◽

Vol 18 (1) ◽

Cited By ~ 68

Author(s):

Hisashi Yamanaka ◽

Yoshiya Tanaka ◽

Tsutomu Takeuchi ◽

Naonobu Sugiyama ◽

Hirotoshi Yuasa ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Kinase Inhibitor ◽

Japanese Patients ◽

Janus Kinase ◽

Extension Study ◽

Open Label ◽

Janus Kinase Inhibitor

Download Full-text

SAT0293 Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of opal balance, an open-label, long-term extension study

10.1136/annrheumdis-2018-eular.3115 ◽

2018 ◽

Cited By ~ 2

Author(s):

P. Nash ◽

L.C. Coates ◽

A.J. Kivitz ◽

P.J. Mease ◽

D.D. Gladman ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Interim Analysis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Extension Study ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy ◽

The Third

Download Full-text

A1.72 Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study1

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-205124.71 ◽

2014 ◽

Vol 73 (Suppl 1) ◽

pp. A31.2-A31 ◽

Cited By ~ 8

Author(s):

Peter Taylor ◽

Mark Genovese ◽

Ed Keystone ◽

Douglas Schlichting ◽

Scott Beattie ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy

Download Full-text

SAT0234 Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 9 years

10.1136/annrheumdis-2018-eular.1733 ◽

2018 ◽

Cited By ~ 1

Author(s):

J. Wollenhaupt ◽

J. Silverfield ◽

E. B. Lee ◽

K. Terry ◽

K. Kwok ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy

Download Full-text

Safety and efficacy of tofacitinib, an oral Janus kinase inhibitor, in patients with active psoriatic arthritis: Interim data from OPAL Balance, an open label, long-term extension study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2017.04.875 ◽

2017 ◽

Vol 76 (6) ◽

pp. AB224

Keyword(s):

Psoriatic Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Extension Study ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy

Download Full-text

FRI0509 Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 24 months in patients with active psoriatic arthritis: interim data from opal balance, an open-label, long-term extension study

10.1136/annrheumdis-2017-eular.1414 ◽

2017 ◽

Cited By ~ 5

Author(s):

P Nash ◽

LC Coates ◽

AJ Kivitz ◽

PJ Mease ◽

DD Gladman ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Extension Study ◽

Open Label ◽

Janus Kinase Inhibitor ◽

Safety And Efficacy

Download Full-text

704 Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Ulcerative Colitis: An Interim Analysis of an Open-Label, Long-Term Extension Study With up to 5.5 Years of Treatment

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000592352.44466.21 ◽

2019 ◽

Vol 114 (1) ◽

pp. S413-S414

Author(s):

Gary R. Lichtenstein ◽

Edward V. Loftus ◽

Arif Soonasra ◽

Nervin Lawendy ◽

Gary Chan ◽

...

Keyword(s):

Ulcerative Colitis ◽

Interim Analysis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Extension Study ◽

Open Label ◽

Janus Kinase Inhibitor

Download Full-text

Tu1857 TOFACITINIB, AN ORAL, SMALL MOLECULE JANUS KINASE INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: ANALYSIS OF AN OPEN-LABEL, LONG-TERM EXTENSION STUDY WITH UP TO 5.9 YEARS OF TREATMENT

Gastroenterology ◽

10.1016/s0016-5085(20)33644-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-1190-S-1191

Author(s):

Gary R. Lichtenstein ◽

Edward V. Loftus ◽

Shu Chen Wei ◽

Aderson O. Damiao ◽

Donna Judd ◽

...

Keyword(s):

Ulcerative Colitis ◽

Small Molecule ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Extension Study ◽

Open Label ◽

Janus Kinase Inhibitor

Download Full-text